parp1 (Cell Signaling Technology Inc)
Structured Review

Parp1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 15345 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parp/PARP+Antibody/pmc13669479-13-0-7
Average 98 stars, based on 15345 article reviews
Images
1) Product Images from "Fc‐Dependent Targeting of the GAS6–MERTK Axis With Monoclonal and Bispecific Antibodies Overcomes Drug Resistance Across EGFR Mutations in Exons 19, 20, and 21"
Article Title: Fc‐Dependent Targeting of the GAS6–MERTK Axis With Monoclonal and Bispecific Antibodies Overcomes Drug Resistance Across EGFR Mutations in Exons 19, 20, and 21
Journal: Advanced Science
doi: 10.1002/advs.78290
Figure Legend Snippet:
Techniques Used: Cell-Signaling
Related Articles
Bioprocessing:Article Title: Apoptosis-inducing potential of tilorone dihydrochloride in triple-negative breast cancer: in silico and in vitro evidences. Article Snippet: Tilorone is an antiviral agent with interferon-inducing properties.. The present study focused on evaluating the apoptosisinducing effects of tilorone in triple-negative breast cancer (TNBC) using in silico and in vitro models.. Molecular docking and dynamics were performed to investigate the interactions of cGAMP and tilorone with human STING. Cell-Signaling:Article Title: Apoptosis-inducing potential of tilorone dihydrochloride in triple-negative breast cancer: in silico and in vitro evidences. Article Snippet: Tilorone is an antiviral agent with interferon-inducing properties.. The present study focused on evaluating the apoptosisinducing effects of tilorone in triple-negative breast cancer (TNBC) using in silico and in vitro models.. Molecular docking and dynamics were performed to investigate the interactions of cGAMP and tilorone with human STING. Article Title: MerTK inhibition by UNC569 triggers DNA damage and JNK/p38 MAPK cascade-driven apoptosis in pancreatic cancer. Article Snippet: .. The following primary antibodies were used: p-Rb (8516), p21 (2947), Snail (3879), cleaved caspase3 (9669), Article Title: Development of Styryl‐Modified 3,4‐Dihydropyrimidin‐2(1 H )‐ones as Potential Antitumor Agents Article Snippet: SDS PAGE were performed using Mini‐PROTEAN TGX Precast Gels (Bio‐Rad) and transferred using Trans‐Blot Turbo Transfer System (Bio‐Rad). .. Primary antibody, other:Article Title: Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil-mediated promotion of DNA damage-driven cytotoxicity Article Snippet: The following primary antibodies were used: Copper transporting ATPase (ATP7A), extracellular regulated kinase 2 (ERK2), phosphorylated (p)-histone H3 (Ser10) from Thermo Fisher Scientific Inc., cleaved caspase-7 (Asp198), p-Chk1 (Ser 345), cyclin B1, galactosidase β (E2U2I), GAPDH (14C10), MDR1/ABCB1 (D3H1Q), p-P53 (S15), PARP, TopBP1(D8G4L), Article Title: Development of Styryl-Modified 3,4-Dihydropyrimidin-2(1H)-ones as Potential Antitumor Agents. Article Snippet: 20 μg lysate was prepared with 2x Laemmli Sample Buffer (1610737, Biorad). Electrophoresis:Article Title: The ribonuclease ZC3H12A stabilizes BRCA1 mRNA in DNA damage response. Article Snippet: .. Samples were then loaded onto 4%-12% Tris polyacrylamide gels and resolved by electrophoresis at 150 V for 1-1.5 h. The proteins were transferred onto nitrocellulose (NC) membranes at 400 mA for 1-3 h. Membranes were blocked with 5% non-fat milk for 1 h at room temperature and subsequently incubated with specific primary antibodies against ZC3H12A (GeneTex, 1:4000), BRCA1 (Proteintech, 1:2000), γH2AX (Sigma, 1:2000), Incubation:Article Title: The ribonuclease ZC3H12A stabilizes BRCA1 mRNA in DNA damage response. Article Snippet: .. Samples were then loaded onto 4%-12% Tris polyacrylamide gels and resolved by electrophoresis at 150 V for 1-1.5 h. The proteins were transferred onto nitrocellulose (NC) membranes at 400 mA for 1-3 h. Membranes were blocked with 5% non-fat milk for 1 h at room temperature and subsequently incubated with specific primary antibodies against ZC3H12A (GeneTex, 1:4000), BRCA1 (Proteintech, 1:2000), γH2AX (Sigma, 1:2000), |
